Investigations of Laser-Assisted Renal Denervation for Treatment of Resistant Hypertension

被引:0
作者
Hwang, Junghyun [1 ,2 ]
Shin, Hwarang [2 ,3 ]
Jung, Minwoo [1 ]
Kang, Hyun Wook [1 ,2 ,3 ,4 ]
机构
[1] Pukyong Natl Univ, Coll Informat Technol & Convergence, Div Smart Healthcare, Biomed Engn, Busan, South Korea
[2] Pukyong Natl Univ, Marine Integrated Biomed Technol Ctr, Busan, South Korea
[3] Pukyong Natl Univ, Ind 4 0 Convergence B Engn, Busan, South Korea
[4] TeCure Inc, Appl R&D, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
diffusing applicator; endovascular; hypertension; renal denervation; resistant hypertension; SYMPATHETIC DENERVATION; BLOOD-PRESSURE; BALLOON CATHETER; ABLATION; ULTRASOUND; STATEMENT; SENSORS; SAFETY; TRIAL;
D O I
10.1002/lsm.23823
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and ObjectivesRenal denervation (RDN) is an emerging surgical treatment for resistant hypertension. However, the current RDN using radiofrequency can cause undesirable thermal damage to the medial and luminal layers due to direct contact between the arterial lumen and energy source. The aim of this study is to evaluate the feasibility of the new laser-assisted RDN by exploring the potential treatment conditions.MethodsFor ex vivo testing, six different treatment conditions (10 and 20 W applied for delivery of 300, 450, and 600 J) were tested on the porcine liver and renal artery (RA) by using a continuous wave 1064 nm laser wavelength. The ablated area in the liver tissue was measured to estimate the extent of the coagulated area. Histological evaluation was performed on the treated RA tissues to confirm the extent of thermal nerve damage.ResultsThe ablated depth, length, and area in the liver tissue increased with laser power and total energy. According to the histological results, 20 W groups yielded more significant damage to the RA nerves than 10 W groups at the total energy of 300 J (0.0 +/- 0.0 mm for 10 W vs. 2.9 +/- 1.0 mm for 20 W), 450 J (1.9 +/- 0.6 mm for 10 W vs. 6.8 +/- 1.5 mm for 20 W), and 600 J (2.9 +/- 0.4 mm for 10 W vs. 7.3 +/- 0.8 mm for 20 W). The treated RA exhibited insignificant medial injury in depth (medial thinning <= 25%), and no difference in the medial thinning was found among the six groups (p = 0.4).ConclusionThe current study demonstrated that the 1064 nm laser at 20 W with delivery of 450 J could effectively damage the RA nerves with no or minimal injury to the surrounding tissue. The proposed laser-assisted RDN may enhance physiological effects with insignificant complications in in vivo situations. Further in vivo studies will be conducted to validate the current findings by evaluating the extent of blood pressure reduction and norepinephrine changes after the laser-assisted RDN on a large animal model.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 50 条
  • [41] Catheter-Based Renal Denervation for Hypertension
    Townsend, Raymond R.
    Sobotka, Paul A.
    CURRENT HYPERTENSION REPORTS, 2018, 20 (11)
  • [42] Renal Denervation in the Treatment of Hypertension
    Ukena, Christian
    Mahfoud, Felix
    Ewen, Sebastian
    Cremers, Bodo
    Laufs, Ulrich
    Boehm, Michael
    CURRENT HYPERTENSION REPORTS, 2013, 15 (04) : 363 - 369
  • [43] Renal denervation for treatment of drug-resistant hypertension
    Esler, Murray
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (02) : 107 - 115
  • [44] Predictors of Renal Denervation Efficacy in the Treatment of Resistant Hypertension
    Tatiana M. Ripp
    Victor F. Mordovin
    Stanislav E. Pekarskiy
    Tamara R. Ryabova
    Marina V. Zlobina
    Andrei E. Baev
    Yana Anfinogenova
    Sergey V. Popov
    Current Hypertension Reports, 2015, 17
  • [45] Renal denervation in treatment-resistant hypertension: a reappraisal
    Persu, Alexandre
    Jin, Yu
    Elmula, Fadl Elmula M. Fadl
    Renkin, Jean
    Hoieggen, Aud
    Kjeldsen, Sverre E.
    Staessen, Jan A.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 21 : 48 - 52
  • [46] Frequency of hypertension resistant to treatment and indication for renal denervation
    Rosenbaum, D.
    Villeneuve, F.
    Gury, C.
    Girerd, X.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2012, 61 (03): : 229 - 233
  • [47] Renal Sympathetic Denervation for Hypertension
    Guber, Kenneth
    Kirtane, Ajay J.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (10): : 2129 - 2140
  • [48] An Update on Catheter-Based Renal Denervation for the Treatment of Hypertension
    Wheaten, Sterling A.
    Zhang, Jiandong
    Stouffer, George A.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2021, 15 (10)
  • [49] Renal Denervation in Moderate Treatment-Resistant Hypertension
    Ott, Christian
    Mahfoud, Felix
    Schmid, Axel
    Ditting, Tilmann
    Sobotka, Paul A.
    Veelken, Roland
    Spies, Aline
    Ukena, Christian
    Laufs, Ulrich
    Uder, Michael
    Boehm, Michael
    Schmieder, Roland E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (20) : 1880 - 1886
  • [50] Impact of renal denervation on cardiac remodeling in resistant hypertension: A meta-analysis
    Xie, Linfeng
    Li, Yuanzhu
    Luo, Suxin
    Huang, Bi
    CLINICAL CARDIOLOGY, 2024, 47 (02)